Cause or effect? Interpreting emerging evidence for dysbiosis in systemic sclerosis
Abstract Systemic sclerosis (SSc) is an immune-mediated fibrotic disease affecting skin, lung and gut which are all sites with an established microbiome. Altered microbial flora may occur and contribute to the initiation, progression or severity of disease. However, dysbiosis could also be secondary...
Main Authors: | Christopher P. Denton, Charles Murray |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-03-01
|
Series: | Arthritis Research & Therapy |
Online Access: | http://link.springer.com/article/10.1186/s13075-019-1872-4 |
Similar Items
-
Systemic Sclerosis
by: Michael Hughes, et al.
Published: (2020-07-01) -
The effect of multiple sclerosis therapy on gut microbiota dysbiosis: a
longitudinal prospective
study
by: Andreea-Cristina Paraschiv, et al.
Published: (2024-04-01) -
B-cell-depletion reverses dysbiosis of the microbiome in multiple sclerosis patients
by: Alba Troci, et al.
Published: (2022-03-01) -
News and failures from recent treatment trials in systemic sclerosis
by: Christopher P. Denton, et al.
Published: (2020-10-01) -
Microbiome dysbiosis is associated with disease duration and increased inflammatory gene expression in systemic sclerosis skin
by: Michael E. Johnson, et al.
Published: (2019-02-01)